Effects of Nifedipine in Achalasia and in Patients With High-Amplitude Peristaltic Esophageal Contractions
- Morris Traube, MD;
- Michio Hongo, MD;
- Laurie Magyar, RN;
- Richard W. McCallum, MD
Abstract
We studied the esophageal effects of nifedipine in 20 patients with achalasia (20 mg sublingually) and nine patients with high-amplitude peristaltic esophageal contractions (nutcracker esophagus) (20 mg orally). In patients with achalasia, nifedipine decreased lower esophageal sphincter (LES) pressure by approximately 30%. In ten patients with achalasia, plasma nifedipine concentrations were 45.3± 17.7 and 57.4 ± 12.8 ng/mL [unk] ± SEM) at 30 and 60 minutes, respectively, after drug administration. In patients with nutcracker esophagus, nifedipine decreased LES pressure by approximately 50% and contraction amplitude in the body of the esophagus by approximately 25%. After comparison was made with our previous results in normal subjects, we concluded that (1) nifedipine decreased LES pressure in patients with achalasia to a similar extent to that noted in normal subjects; (2) plasma concentrations measured after 20 mg of nifedipine given sublingually to achalasic patients were similar to those found under similar circumstances in normal subjects; and (3) nifedipine decreased LES pressure and contraction amplitude in patients with nutcracker esophagus to a greater extent than was found in normal subjects. These results suggest that double-blind, placebo-controlled clinical trials of nifedipine in the treatment of achalasia or nutcracker esophagus are indicated.
(JAMA 1984;252:1733-1736)
Footnotes
-
Reprint requests to Gastroenterology Unit, 92 LMP, Yale University School of Medicine, 333 Cedar St, PO Box 3333, New Haven, CT 06510 (Dr McCallum).
